- About WXPress
- WXPress is your window into the world of WuXi AppTec and our global partners.
- Sitemap
- Events
- Contact
- Please reach out with any business inquires.
- communications@wuxiapptec.com
© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy
April 26, 2022 ~ April 28, 2022
8AM - 11AM PDT | 11AM - 2PM EDT
Dear Colleagues and Friends,
We are pleased to report that thousands of participants from around the world united once again for the 2022 WuXi Healthcare Forum. This year, we gathered under the theme of “Call To Action” to support the World Health Organization’s key initiatives in tackling global health challenges head-on, and to collaboratively advance better healthcare solutions.
To our esteemed guest speakers, THANK YOU for leading the way with new thinking and actionable approaches as we work together to shape the future of healthcare.
Special thanks to our supportive partners: UK BioIndustry Association, BioCentury, Biocom California, Clarivate, California Life Sciences, Endpoints News, GEN, MBC BioLabs, Medicon Valley Alliance, Pharma Intelligence | Informa, and Swiss Biotech Association.
Please follow us on Twitter, LinkedIn, and YouTube to stay up-to-date on upcoming WuXi AppTec news and events.
Hui Cai, Program Chair, VP & Head of Content, WuXi AppTec
Steve Yang, Co-CEO, WuXi AppTec
A conversation between Sir Menelas Pangalos, EVP & President, BioPharmaceuticals R&D, AstraZeneca, and Steve Yang, Co-CEO, WuXi AppTec
A conversation between Emilio Emini, CEO, Bill & Melinda Gates Medical Research Institute, and Zina Affas Besse, Deputy Head, Healthcare Private Equity, AXA Investment Managers Group
Walter Koroshetz, Director, National Institute of Neurological Disorders & Stroke, National Institutes of Health
A conversation between Mariell Jessup, Chief Science & Medical Officer, American Heart Association, and Faiez Zannad, Emeritus Professor of Therapeutics & Cardiology, Université de Lorraine, Inserm; Chairman, CVCT, Paris, France
A conversation between Harold Burstein, Institute Physician, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School, Arif Kamal, Chief Patient Officer, American Cancer Society; Physician Quality & Outcomes Officer, Duke Cancer Institute, and Tony Mok, Li Shu Fan Professor of Clinical Oncology, The Chinese University of Hong Kong
Erin Duffy, Chief of Research & Development, CARB-X
Valeria Gigante, Team Lead, AMR Division, World Health Organization, Geneva, Switzerland
Timothy Jinks, Head of Infectious Diseases Interventions, The Wellcome Trust
Henry Skinner, CEO, AMR Action Fund
Session Leader: Jenny Yip, Managing Partner, Adjuvant Capital
Richard Soll, Head of Boston Office & Senior Advisor of Strategic Initiatives, WuXi AppTec
Minzhang Chen, Co-CEO, WuXi AppTec
Stephen Hahn, CEO-Partner, Flagship Pioneering; CEO, Harbinger Health
Laurence Barker, Partner, The Dementia Discovery Fund
Christina Isacson, Partner, Lightstone Ventures
Philip Scheltens, Head, Dementia Fund, EQT Life Sciences
Session Leader: Rana Al-Hallaq, Partner, Pfizer Ventures
A conversation between Todd Sherer, EVP, Research Strategy, The Michael J. Fox Foundation for Parkinson's Research, and Andrew Siderowf, Hurtig-Stern Professor in Neurology, University of Pennsylvania Perelman School of Medicine
Sekar Kathiresan, CEO, Verve Therapeutics
Michael Mendelsohn, Founder & Chairman, Cardurion Pharmaceuticals
Christopher de Souza, Director, Broadview Ventures
Claudia Ulbrich, CEO & Co-Founder, Cardior Pharmaceuticals
Session Leader: Simone Fishburn, VP & Editor in Chief, BioCentury Inc.
Rajesh Chopra, Venture Partner, Head of Oncology, Apple Tree Partners
Adam Friedman, President, Corporate Strategy & Business Development, Scorpion Therapeutics
Luba Greenwood, CEO, Kojin Therapeutics
KT Moortgat, Healthcare Venture Investor, Investment Partner, Droia Ventures
Lewis Williams, Co-founder, Chairman & CEO, Walking Fish Therapeutics, Inc.
Session Leader: Dave Madge, VP of Discovery Services, WuXi AppTec
Jocelyne Bath, Managing Director, OXGENE
Richard Connell, SVP & US/EU COO, WuXi AppTec
A conversation between William Hait, EVP, Chief External Innovation, Medical Safety & Global Public Health Officer, Johnson & Johnson, and Julie Grant, General Partner, Canaan
Andrew Bruce, CEO, MediSix Therapeutics
Wee Joo Chng, Executive Director, Singapore Translational Cancer Consortium; Director & Senior Consultant, National University Cancer Institute, Singapore, NUHS
Boon Tong Koh, Executive Director, Bioprocessing Technology Institute, A*STAR, Singapore
Francesca Lim, Assistant Medical Director, Cell Therapy Facility, Health Science Authority (HSA); Senior Consultant Hematologist, Singapore General Hospital
Yann Chong Tan, Managing Director, EVX Ventures; CEO, Nuevocor; CSO, Cargene Therapeutics
Session Leader: Danny Soon, CEO, Consortium for Clinical Research & Innovation, Singapore; Executive Director, Singapore Clinical Research Institute
Opening Remarks by Steve Bates, CEO, UK BioIndustry Association
Billy Boyle, Co-Founder & CEO, Owlstone Medical
Ryan Cawood, CSO, WuXi Advanced Therapies & OXGENE
Kathryn Corzo, COO, bit.bio
Jack O'Meara, CEO, Ochre Bio
Session Leader: Michael Ward, Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate
Vineeta Agarwala, General Partner, Andreessen Horowitz
Rohit Chandra, Chief Digital Officer, Cleveland Clinic
Daphne Koller, CEO & Founder, insitro
Session Leader: Ben Robbins, Venture Partner, GV
